Loading organizations...
Loading organizations...
Sempulse develops a non-invasive vital signs monitoring platform, centered on its patented, FDA-cleared Halo sensor. This compact device affixes to the ear/neck, continuously collecting physiological data like blood pressure, heart rate, temperature. The Halo Platform, via mobile app and cloud, leverages AI for real-time analysis and remote patient management.
Founded in 2015 by engineers and former U.S. military officers, Sempulse identified a critical need. Their insight focused on robust, continuous, remote vital signs monitoring in challenging environments lacking adequate traditional methods. This spurred their durable, accurate solution for demanding applications.
Sempulse supports medical professionals in emergency, ICU, military, and disaster response. Its vision transforms vital signs monitoring via clinical-grade data and intelligent analysis. This empowers caregivers to make informed decisions, optimizing resource allocation and enhancing patient outcomes through proactive, centralized health management.
Sempulse is a medical device manufacturer specializing in wearable technology for non-invasive vital signs monitoring. Its flagship product, the FDA-cleared Halo Vital Signs Monitor, is a compact sensor that adheres behind the ear and neck, tracking key metrics like non-invasive blood pressure (NIBP), SpO2, pulse rate, heart rate, respiratory rate, core body temperature, skin temperature, activity, posture, geolocation, and environmental data in real-time.[1][2][3] The Halo integrates with the LiveCharts app and Command Cloud platform, enabling remote monitoring of hundreds of patients via smartphone, automated AI-driven alerts, prioritization, and a secure centralized database for collaborative care.[1][2][3]
Sempulse serves medical professionals in emergency departments, ICUs, telemedicine, remote patient monitoring, military field triage, law enforcement, disaster response, industrial settings, and HAZMAT scenarios. It solves the problem of inefficient, invasive vital signs monitoring by providing continuous, motion-tolerant data to prioritize care, reduce emotional decision-making in triage, and improve outcomes when seconds count—demonstrated by its first confirmed life saved in Gwinnett County, GA, in 2024.[2][3][4][5] With under 25 employees and revenue below $5 million, the company shows growth momentum through recent milestones like presentations at PwC's 2025 Emerging Tech Exchange and exhibitions at SOMA Scientific Assembly 2025.[1][4][5]
Founded in 2016, Sempulse emerged from a vision to innovate wearable medical tech for real-time physiological monitoring beyond hospital walls. CEO and Founder Kurt Stump leads the company, headquartered in San Marcos, TX (with early ties to Buckeye, AZ), as a medical device manufacturer focused on patented, FDA-cleared solutions.[1][3][4][5] The idea crystallized around creating the "first true FDA-cleared medical wearable"—a non-invasive sensor for at-rest or on-the-go vital signs capture, addressing gaps in emergency response, military training, and remote care.[2][3]
Early traction built through development of the Halo platform, culminating in FDA clearance and real-world validation. A pivotal moment came in October 2024 when the Halo saved its first life during an operational incident in Gwinnett County, GA, where real-time data from the sensor, app, and cloud enabled life-saving intervention—marking a historic milestone announced December 16, 2024.[3][4][5]
Sempulse rides the wave of wearable health tech and remote patient monitoring (RPM), accelerated by post-pandemic demands for telemedicine, AI triage, and resilient emergency systems amid climate disasters and global conflicts. Its timing aligns with rising needs for non-invasive tools in austere environments—military, border ops, HAZMAT—where traditional monitoring fails, fueled by AI advancements in predictive analytics and edge computing.[2][3][5]
Market forces like FDA fast-tracking wearables, defense spending on medtech, and industrial safety regs favor Sempulse, positioning it as an "innovation accelerator" for scalable, integrable solutions. By influencing ecosystems through integrations (e.g., BATDOK) and demos at events like SOMA 2025, it pushes boundaries in out-of-hospital care, potentially reducing mortality in high-stakes scenarios.[4][5]
Sempulse is poised for expansion through partnerships in defense, EMS, and telehealth, leveraging its life-saving proof-of-concept to secure contracts and scale deployments. Trends like AI-enhanced RPM, multimodal wearables, and disaster-resilient tech will propel it, especially with integrations and global events amplifying visibility.[4][5]
Its influence may evolve from niche innovator to ecosystem standard-setter, as real-time data platforms become essential for next-gen triage. This builds on its core strength: transforming vital signs monitoring to save lives where every second counts, echoing the breakthrough that marked its first milestone.[3]